Anika Therapeutics Inc.

ANIK | NASDAQ

Price Alert Chart Builder DCF Calculator

$20.93

+$0.23 (+1.11%)

Sep 22, 2026, 11:46 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.11%

(1D)

Rating

Updated: Aug 26, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $280.11M

1D Range

20.60 20.98

52W Range

8.67 22.88

Valuation (TTM)

PE -76.67

PB 2.02

EV/EBITDA 96.40

Valuation (NTM)

Forward PE 20.34

Forward PEG 8.06

Price Target $21

Cash Flow

FCF Yield 0.2%

SBC Adj. FCF Yield -4.5%

SBC Impact -2339.3%

Margins

Gross Margin 62.2%

Operating Margin -4.2%

FCF Margin 0.5%

Growth (CAGR)

Revenue 3Y | 5Y -9.4% | -2.5%

Dil EPS 3Y | 5Y 75.9% | -7.0%

FCF 3Y | 5Y -152.9% | -39.4%

Returns

ROA -2.1%

ROE -2.7%

ROIC -3.2%

Financial Health

Net Cash

$15.1M

Current Ratio 4.48

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core ...

Sector Healthcare

Industry Medical - Specialties

Employees 235

IPO Date May 2, 1993

Website www.anika.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$21

Upside

+0.33%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞